FIELD: medicine, oncology, pharmacy.
SUBSTANCE: invention relates to an agent diminishing toxicity of anti-tumor preparations that comprises benzamide as a pharmacologically active agent in the range of doses from 5 to 100 mg/kg. Agent provides the protection of cardiotoxicity and neurotoxicity induced by cytostatics.
EFFECT: valuable medicinal properties of agent.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINING ONDANSETRON AND BENZAMIDE | 2003 |
|
RU2228752C1 |
| ANTIEMETIC AGENT BENZAMIDE | 2002 |
|
RU2205009C1 |
| SPECIFIC COMBINED THERAPY OF MALIGNANT TUMOURS WITH CYTOSTATIC AGENT AND ITS MODIFYING AGENT | 2015 |
|
RU2571551C1 |
| PHARMACEUTICAL COMPOSITION BASED ON PALLADIUM COMPOUND | 2015 |
|
RU2613305C2 |
| METHOD FOR SIMULATING CHRONIC CYTOSTATIC MYELOSUPPRESSION | 2012 |
|
RU2488890C1 |
| MEDICINAL AGENT STIMULATING ERYTHROIDE HEMOPOIESIS GERM AT CYTOSTATIC MYELODEPRESSION STATES | 1992 |
|
RU2061475C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING ONDANSETRON AND METHACINE | 2001 |
|
RU2185825C1 |
| PREPARATION INCREASING ANTITUMOR AND ANTIMETASTATIC ACTIVITY OF CYCLOPHOSPHAN | 2002 |
|
RU2225720C1 |
| AGENT AND METHOD OF ANTITUMOR ACTIVITY INCREASE AND CYTOSTATIC THERAPY BY-SIDE EFFECTS DECREASE | 1995 |
|
RU2078578C1 |
| POLYMER CONTAINING MEDICINAL AGENT BASED ON ANTITUMOR AGENT ETOPOSIDE | 2015 |
|
RU2595859C1 |
